Lupus Clinical Trials near Baltimore, MD
15 studies for Lupus are recruiting at 17 sites within 50 miles of Baltimore, Maryland, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Lupus trials in the US or all trials near Baltimore.
Recruiting now
Lupus studies enrolling near Baltimore
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest sites: Johns Hopkins University/Sidney Kimmel Cancer Center (Baltimore, MD); National Cancer Institute Developmental Therapeutics Clinic (Bethesda, MD)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
NCT06527872
- Observational
- Ages 18 years and older
- Sex: All
Nearest site: GSK Investigational Site (Baltimore, MD)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
NCT07085104
- Phase 1
- Ages 18 to 74 years
- Sex: All
Nearest site: Johns Hopkins Hospital (Baltimore, MD)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
NCT06617325
- Phase 3
- Ages 16 years and older
- Sex: All
Nearest site: Sl0044 50730 (Rockville, MD)
- Distance to nearest recruiting site
- ~32 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285
- Observational
- Ages 16 years and older
- Sex: All
Nearest site: Arthritis & Rheumatism Associates (Rockville, MD)
- Distance to nearest recruiting site
- ~32 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
NCT07611214
- Phase 4
- Ages 18 to 75 years
- Sex: All
Nearest site: Arthritis and Rheumatism Associates (Rockville, MD)
- Distance to nearest recruiting site
- ~32 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Systemic Lupus Erythematosus
NCT00001372
- Observational
- Ages 3 to 120 years
- Sex: All
- Accepts healthy volunteers
Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)
- Distance to nearest recruiting site
- ~34 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
NCT05440422
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)
- Distance to nearest recruiting site
- ~34 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
NCT05567198
- Observational
- Ages 18 to 120 years
- Sex: Female
Nearest site: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (Bethesda, MD)
- Distance to nearest recruiting site
- ~34 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
NCT06032923
- Phase 1/2
- Ages 18 to 120 years
- Sex: Female
- Accepts healthy volunteers
Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)
- Distance to nearest recruiting site
- ~34 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
NCT07262983
- Phase 1
- Ages 12 to 120 years
- Sex: All
Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)
- Distance to nearest recruiting site
- ~34 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
NCT04833465
- Observational
- Ages 5 to 21 years
- Sex: All
Nearest site: Children's National Health System (Washington D.C., DC)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
NCT05835310
- Phase 3
- Ages 5 to 17 years
- Sex: All
Nearest site: Research Site (Washington D.C., DC)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Research Accelerated by You Lupus Registry
NCT06927219
- Observational
- Ages Any age
- Sex: All
Nearest site: Online Registry - No Physical Site Required (Washington D.C., DC)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
NCT07089121
- Phase 1/2
- Ages 12 years and older
- Sex: All
Nearest site: H01- Children's National Hospital (Washington D.C., DC)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Lupus clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.